Cartia XT 300mg Recall: Aluminum Residue Hazard
Actavis recalls Cartia XT 300mg capsules due to aluminum residue on the shell. Check your lot number and expiration date for affected units.
Recall notice
Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell
Contact the company
What happened, in plain English
Actavis Laboratories is recalling specific bottles of Cartia XT (diltiazem HCl) 300 mg extended-release capsules because fine aluminum residue may be present on the exterior of the capsule shell. This recall affects 2,628 bottles distributed nationwide. The record does not specify a remedy or return process for consumers. Read more at govinfonow.com/recall/44819-actavis-laboratories-fl-inc-recalls-cartia-xt-diltiazem-hcl-extended.
Source Summary by GovInfoNow · govinfonow.com/recall/44819-actavis-laboratories-fl-inc-recalls-cartia-xt-diltiazem-hcl-extended · Updated October 12, 2026 · FDA enforcement record: FDA #D-0488-2015
Cite this page
“Cartia XT 300mg Recall: Aluminum Residue Hazard.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44819-actavis-laboratories-fl-inc-recalls-cartia-xt-diltiazem-hcl-extended. Based on FDA recall #D-0488-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0488-2015%22&limit=1).
Why it’s dangerous
The hazard involves fine residue or dust identified as aluminum on the exterior of the capsule shell. The record does not describe the health effects or mechanism of injury from ingesting this substance.
Who’s affected
Patients prescribed Cartia XT 300 mg capsules who purchased the affected lot between manufacture and the recall date. The risk is limited to those with the specific contaminated bottles.
How to tell if you have this one
Look for Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg in 90-count bottles. Check for NDC 62037-0600-90, Lot # 956000M, Expiration Aug 2016, and UPC 3-6203760090-6.
- Brand
Cartia XT- Product
Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only- Category
Drug
What to do — step by step
Check Your Bottle
Verify if your bottle matches Lot # 956000M, Exp. Aug 2016, and NDC 62037-0600-90.
Contact Your Pharmacist
Since the remedy is not stated in the record, consult your healthcare provider or pharmacist for guidance on what to do with the medication.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0488-2015 (March 26, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0488-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.